Global Single Cell Multiomics Market Report 2022: Significant Shift Towards Personalized Medicine Driving 18.6% Growth - Yahoo Finance

2 years ago 38

, /PRNewswire/ -- The "Global Single Cell Multiomics Market 2021-2031 by Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Region: Trend Forecast and Growth Opportunity" study has been added to  ResearchAndMarkets.com's offering.

Research and Markets Logo

Research and Markets Logo

Global azygous compartment multiomics marketplace volition scope $14,369.5 million by 2031, increasing by 18.6% annually implicit 2021-2031, driven by the rising prevalence of chronic diseases on with the aging population, the wide merchandise adoption for visualization and analysis, technological advancements on with the rising R&D investment, and the important maturation successful the pharmaceutical manufacture particularly personalized medication.


In-depth qualitative analyses see recognition and probe of the pursuing aspects:

  • Market Structure

  • Growth Drivers

  • Restraints and Challenges

  • Emerging Product Trends & Market Opportunities

  • Porter's Five Forces

The inclination and outlook of planetary marketplace is forecast successful optimistic, balanced, and blimpish presumption by taking into relationship of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is utilized to quantify planetary azygous compartment multiomics marketplace successful each facet of the classification from perspectives of Product Type, Omics Type, Application, Sample Type, Workflow, End User, and Region.

Based connected Product Type, the planetary marketplace is segmented into the pursuing sub-markets with yearly gross ($ mn) for 2021-2031 included successful each section.

  • Instruments

  • Consumables

  • Software

Based connected Omics Type, the planetary marketplace is segmented into the pursuing sub-markets with yearly gross ($ mn) for 2021-2031 included successful each section.

  • Single Cell Genomics (SCG)

  • Single Cell Transcriptomics (SCT)

  • Single Cell Proteomics (SCP)

  • Single Cell Metabolomics (SCM)

By Application, the planetary marketplace is segmented into the pursuing sub-markets with yearly gross ($ mn) for 2021-2031 included successful each section.

  • Clinical Research

  • Oncology

  • Cell Therapy

  • Immunology

  • Neurology

  • Cell Biology

  • Other Types of Clinical Research

  • Translation Research

  • Synthetic Biology

By Sample Type, the planetary marketplace is segmented into the pursuing sub-markets with yearly gross ($ mn) for 2021-2031 included successful each section.

  • Human Samples

  • Cancer Tissues

  • Stem Cells

  • Immune Cells

  • Brain Cells

  • Other Human Samples

  • Animal Samples

  • Microbial Samples

By Workflow, the planetary marketplace is segmented into the pursuing sub-markets with yearly gross ($ mn) for 2021-2031 included successful each section.

  • Single-Cell Isolation and Dispensing

  • Fluorescence-Activated Cell Sorting (FACS)

  • Microfluidics

  • Magnetic-Activated Cell Sorting (MACS)

  • Random Seeding

  • Manual Cell Picking

  • Laser Capture Microdissection

  • Other Technologies of Single-Cell Isolation and Dispensing

  • Single-Cell Analysis

  • Polymerase Chain Reaction

  • Next-Generation Sequencing

  • Mass Cytometry

  • Mass Spectrometry

  • Other Technologies of Single-Cell Analysis

By End User, the planetary marketplace is segmented into the pursuing sub-markets with yearly gross ($ mn) for 2021-2031 included successful each section.

  • Research and Academic Laboratories

  • Biopharmaceutical and Biotech Companies

  • Contract Research Organizations (CROs)

  • Other End Users

Geographically, the pursuing regions unneurotic with the listed national/local markets are afloat investigated:

  • North America (U.S., Canada, and Mexico)

  • Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)

  • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

  • South America (Brazil, Chile, Argentina, Rest of South America)

  • MEA (UAE,Saudi Arabia, South Africa and Rest of MEA)

Selected Key Players:

  • 10x Genomics, Inc.

  • 1CellBio, Inc.

  • Becton, Dickinson and Company

  • Berkeley Lights, Inc.

  • BGI Genomics Co., Ltd.

  • Bio-Rad Laboratories, Inc.

  • Bio-Techne Corporation

  • BioTuring, Inc.

  • Danaher Corporation (Cytiva Life Sciences)

  • Dolomite Bio

  • Fluidigm Corporation

  • Fluxion Biosciences

  • Illimina, Inc

  • Mission Bio, Inc.

  • Namocell, Inc.

  • NanoString Technologies, Inc.

  • Parse Biosciences, Inc.

  • Proteona

  • Qiagen N.V.

  • RareCyte, Inc.

  • Scipio Biosciences SAS

  • Shilps Sciences

  • Takara Bio Inc. (Takara Holdings)

  • Thermo Fisher Scientific Inc.

Key Topics Covered:

1 Introduction

2 Market Overview and Dynamics

3 Segmentation of Global Market by Product Type

4 Segmentation of Global Market by Omics Type

5 Segmentation of Global Market by Application

6 Segmentation of Global Market by Sample Type

7 Segmentation of Global Market by Workflow

8 Segmentation of Global Market by End User

9 Segmentation of Global Market by Region

10 Competitive Landscape

For much accusation astir this study sojourn https://www.researchandmarkets.com/r/n3w6s8

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Logo:  https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

Cision

Cision

View archetypal content:https://www.prnewswire.com/news-releases/global-single-cell-multiomics-market-report-2022-significant-shift-towards-personalized-medicine-driving-18-6-growth-301665121.html

SOURCE Research and Markets

Read Entire Article